CUEDC2 modulates cardiomyocyte oxidative capacity by regulating GPX1 stability

Zhao, Jian, Bing, Liang, Xin, Pan, Guang, Xu, Sai-sai, Guo, Ting, Li, Tao, Zhou, Ying-bin, Xiao, Ai‐Ling, Li

EMBO Molecular Medicine |

The irreversible loss of cardiomyocytes due to oxidative stress is the main cause of heart dysfunction following ischemia/reperfu- sion (I/R) injury and ageing-induced cardiomyopathy. Here, we report that CUEDC2, a CUE domain-containing protein, plays a critical role in oxidative stress-induced cardiac injury. Cuedc2?/? cardiomyocytes exhibited a greater resistance to oxidative stress- induced cell death. Loss of CUEDC2 enhanced the antioxidant capacity of cardiomyocytes, promoted reactive oxygen species (ROS) scavenging, and subsequently inhibited the redox-dependent activation of signaling pathways. Notably, CUEDC2 promoted E3 ubiquitin ligases tripartite motif-containing 33 (TRIM33)-mediated the antioxidant enzyme, glutathione peroxidase 1 (GPX1) ubiquiti- nation, and proteasome-dependent degradation. Ablation of CUEDC2 upregulated the protein level of GPX1 in the heart signifi- cantly. Strikingly, in vivo, the infarct size of Cuedc2?/? heart was significantly decreased after I/R injury, and aged Cuedc2?/? mice preserved better heart function as the overall ROS levels in their hearts were significantly lower. Our results demonstrated a novel role of CUEDC2 in cardiomyocyte death regulation. Manipulating CUEDC2 level might be an attractive therapeutic strategy for promoting cardiomyocyte survival following oxidative stress- induced cardiac injury.